In this report, the research team studied the high intensity focused ultrasound (HIFU), cryotherapy, brachytherapy, and external beam radiation.
HIFU is a treatment that using high frequency ultrasound waves concentrated on body tissues, those tissues heat up and die.
Cryotherapy is a way of killing cancer cells by freezing them, as a treatment for people with early stage prostate cancers that have not spread beyond the prostate gland.
Brachytherapy (internal radiotherapy) is radiotherapy given from inside the prostate gland. There are two approaches, permanent (low dose rate, or LDR) brachytherapy and Temporary (high dose rate, or HDR) brachytherapy.
External beam radiation therapy (EBRT): In EBRT, beams of radiation are focused on the prostate gland from a machine outside the body. This type of radiation can be used to try to cure earlier stage cancers, or to help relieve symptoms such as bone pain if the cancer has spread to a specific area of bone.
Scope of the Report:This report focuses on the Prostate Cancer Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Prostate cancer incidence in America and Europe are higher other areas. Hence the development of Prostate Cancer Devices is faster than other areas. The key manufacturers focus on America and Europe, including Bard, Healthtronics, Elekta, Varian Medical Systems, Galil Medical, SonaCare Medical, Eckert & Ziegler, AccuTarget and EDAP TMS, Intuitive Surgical, Accuray and Nuesoft
America and Europe are the major sales markets, with global market share of 52.90% and 26.90% in 2014. China is a potential market, with increase of Prostate Cancer incidence, the demand of Prostate Cancer Devices is gradually increased year by year. Nevertheless, the exorbitant price is the significant factor which limit the its popularization
The worldwide market for Prostate Cancer Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers Elekta
Varian Medical Systems
Bard Medical
Eckert & Ziegler
Healthtronics
Galil Medical
AccuTarget
SonaCare Medical
EDAP TMS
Accuray
Nuesoft
Intuitive Surgical
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers High Intensity Focused Ultrasound (HIFU) Devices
Cryotherapy Devices
Brachytherapy Devices
External Beam Radiation Therapy (EBRT)
Surgery
Market Segment by Applications, can be divided into Cryotherapy
External Beam Radiation Therapyx
Cryotherapy
Brachytherapy
Other
There are 15 Chapters to deeply display the global Prostate Cancer Devices market.
Chapter 1, to describe Prostate Cancer Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Prostate Cancer Devices, with sales, revenue, and price of Prostate Cancer Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Prostate Cancer Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Prostate Cancer Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025;
Chapter 13, 14 and 15, to describe Prostate Cancer Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
